Takotsubo cardiomyopathy or hidden cardiotoxic event by rituximab

Rituximab is a genetically engineered chimeric mouse/human monoclonal antibody representing a glycosylated immunoglobulin (Ig) with human IgG1 constant regions and murine light-chain and heavy-chain variable region sequences. The antibody is produced by mammalian cell suspension culture and purified